In South Africa, various point-of-care hemoglobin meters are used. However, the regulatory framework for approval, implementation and oversight of use of point-of-care hemoglobin meters is suboptimal. We assessed the diagnostic accuracy of the HemoCue Hb 301, STAT-Site MHgband URIT-12 point-of-care hemoglobin meters, compared to a central laboratory based reference assay, in a central laboratory and a community based clinic in Durban, South Africa. Differences in performance of the point-of-care assays, compared to the reference assay, were more pronounced in the community based clinic. Results were reasonable for the HemoCue Hb301, but poor for the STAT-Site MHgband the URIT-12. Poor test performance of point-of-care hemoglobin meters, and inadequate evaluations and oversight in South Africa, leads to suboptimal clinical care and clinical research, and increased costs. There is a need for proper evaluation and quality assurance of point-of-care tests, the results of which should be made widely available to key stakeholders.
CITATION STYLE
Jaggernath, M., Naicker, R., Madurai, S., Brockman, M. A., Ndung’u, T., & Gelderblom, H. C. (2016). Diagnostic accuracy of the HemoCue Hb 301, STAT-Site MHgband URIT-12 point-of-care hemoglobin meters in a central laboratory and a community based clinic in Durban, South Africa. PLoS ONE, 11(4). https://doi.org/10.1371/journal.pone.0152184
Mendeley helps you to discover research relevant for your work.